Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Theophylline for Dyspnea in Cancer Patients
NCT00003684Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Mar 1998
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of theophylline in Dyspnea, sponsored by Canadian Cancer Trials Group. Started Mar 1998; status: completed.
02
Drugs
theophylline
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT00003684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003684.